296 related articles for article (PubMed ID: 12090726)
1. Angiotensin II as a pro-inflammatory mediator.
Phillips MI; Kagiyama S
Curr Opin Investig Drugs; 2002 Apr; 3(4):569-77. PubMed ID: 12090726
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells.
Esteban V; Ruperez M; Sánchez-López E; Rodríguez-Vita J; Lorenzo O; Demaegdt H; Vanderheyden P; Egido J; Ruiz-Ortega M
Circ Res; 2005 May; 96(9):965-73. PubMed ID: 15831814
[TBL] [Abstract][Full Text] [Related]
3. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
Strawn WB
Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis.
Sahar S; Dwarakanath RS; Reddy MA; Lanting L; Todorov I; Natarajan R
Circ Res; 2005 May; 96(10):1064-71. PubMed ID: 15860756
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs.
Tham DM; Martin-McNulty B; Wang YX; Wilson DW; Vergona R; Sullivan ME; Dole W; Rutledge JC
Physiol Genomics; 2002 Oct; 11(1):21-30. PubMed ID: 12361987
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes.
Kranzhöfer R; Browatzki M; Schmidt J; Kübler W
Biochem Biophys Res Commun; 1999 Apr; 257(3):826-8. PubMed ID: 10208867
[TBL] [Abstract][Full Text] [Related]
7. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
[TBL] [Abstract][Full Text] [Related]
8. Contribution of angiotensin-converting enzyme and angiotensin II to ischemic stroke: their role in the formation of stable and unstable carotid atherosclerotic plaques.
Morioka M; Hamada J; Hashiguchi A; Hasegawa Y; Todaka T; Yano S; Kai Y; Miura M; Fujioka S; Ushio Y
Surg Neurol; 2004 Oct; 62(4):292-301; discussion 301-3. PubMed ID: 15451269
[TBL] [Abstract][Full Text] [Related]
9. Changes of gene expression profiles in macrophages stimulated by angiotensin II--angiotensin II induces MCP-2 through AT1-receptor.
Tone A; Shikata K; Ogawa D; Sasaki S; Nagase R; Sasaki M; Yozai K; Usui HK; Okada S; Wada J; Shikata Y; Makino H
J Renin Angiotensin Aldosterone Syst; 2007 Mar; 8(1):45-50. PubMed ID: 17487826
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor.
Wassmann S; Stumpf M; Strehlow K; Schmid A; Schieffer B; Böhm M; Nickenig G
Circ Res; 2004 Mar; 94(4):534-41. PubMed ID: 14699015
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes.
Tsuchiya K; Yoshimoto T; Hirono Y; Tateno T; Sugiyama T; Hirata Y
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E771-8. PubMed ID: 16705055
[TBL] [Abstract][Full Text] [Related]
12. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
[TBL] [Abstract][Full Text] [Related]
13. RhoA mediates angiotensin II-induced phospho-Ser536 nuclear factor kappaB/RelA subunit exchange on the interleukin-6 promoter in VSMCs.
Cui R; Tieu B; Recinos A; Tilton RG; Brasier AR
Circ Res; 2006 Sep; 99(7):723-30. PubMed ID: 16960103
[TBL] [Abstract][Full Text] [Related]
14. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
Vaziri ND; Bai Y; Ni Z; Quiroz Y; Pandian R; Rodriguez-Iturbe B
J Pharmacol Exp Ther; 2007 Oct; 323(1):85-93. PubMed ID: 17636006
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-II behaves as an endogenous pro-inflammatory molecule.
Das UN
J Assoc Physicians India; 2005 May; 53():472-6. PubMed ID: 16124358
[TBL] [Abstract][Full Text] [Related]
16. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].
Galle J
Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336
[TBL] [Abstract][Full Text] [Related]
17. Effects of central injection of angiotensin-converting-enzyme inhibitor and angiotensin type 1 receptor antagonist on the brain NF-kappaB and AP-1 activities of rats given LPS.
Watanabe K; Taniguchi M; Miyoshi M; Shimizu H; Imoto T; Sato K; Watanabe T
Peptides; 2006 Jun; 27(6):1538-46. PubMed ID: 16356591
[TBL] [Abstract][Full Text] [Related]
18. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
19. The potential role of AT(1)-receptor blockade in the prevention and reversal of atherosclerosis.
Papademetriou V
J Hum Hypertens; 2002 Aug; 16 Suppl 3():S34-41. PubMed ID: 12140726
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade.
Dandona P; Dhindsa S; Ghanim H; Chaudhuri A
J Hum Hypertens; 2007 Jan; 21(1):20-7. PubMed ID: 17096009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
